Announcement on Obtaining Approval for Production of Tofacitinib Citrate Sustained-Release Tablets

About this update from Shanghai Pharmaceuticals Holding Co. Ltd. Class A

Announcement on Obtaining Approval for Production of Tofacitinib Citrate Sustained-Release TabletsThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Pharmaceuticals Holding Co. Ltd. Class A